Effect of moxestrol on haloperidol-induced changes in striatal acetylcholine levels and dopamine turn-over.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D045166:Estradiol Congeners / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology*; D007016:Hypophysectomy; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism
D045166:Estradiol Congeners; D011954:Receptors, Dopamine; D004997:Ethinyl Estradiol; C011310:moxestrol; D006220:Haloperidol; D000109:Acetylcholine; D004298:Dopamine